Fund returns as of the current month end,* (unless otherwise noted)

Details Sales
Charge
YTD*
as of
1
Year
3
Year
5
Year
10
Year
Since
Inception
Inception
Date
Expense
Ratio
Share Class: A
Symbol: HRCPX
CUSIP: 14214L106
Excluded 1.00%
Included
Share Class: C**
Symbol: HRCCX
CUSIP: 14214L205
Excluded 1.75%
Included
Share Class: I1
Symbol: HRCIX
CUSIP: 14214L304
N/A 0.75%
Share Class: R62
Symbol: HRCUX
CUSIP: 14214L601
N/A Gross Expense Ratio
0.67%
Net Expense Ratio
(after waivers)
0.65%

*Year-to-date returns are usually updated by 6:30pm, Eastern Time, the current business day.

(1) As a part of the August 3 conversion of the Carillon ClariVest Capital Appreciation Fund to an exchange traded fund, all outstanding Class A, Class C and Class R-6 shares were converted into Class I shares on July 10, 2026. Class A, Class C or Class R-6 shares shareholders, will automatically become Class I shareholders.

Class I shares are available for qualified institutions and individual investors purchasing shares for their own account with a minimum initial investment of $1,000. A fund may waive this minimum amount at its discretion. Qualified institutions include corporations, banks, insurance companies, endowments, foundations and trusts.

Class I shares are available for qualified institutions and individual investors purchasing shares for their own account with a minimum initial investment of $1,000. A fund may waive this minimum amount at its discretion. Qualified institutions include corporations, banks, insurance companies, endowments, foundations and trusts.

Performance data quoted represents past performance which does not guarantee future results. The investment return and principal value will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Net performance reflects a front-end sales charge or 4.75% for class A shares. A 1% contingent deferred sales charge for class C shares is charged on redemptions made within 12 months of purchase, but not at one year. The Fund’s investment adviser, Carillon Tower Advisers, Inc. has contractually agreed to waive or reimburse certain fees and expenses through April 30, 2026 as follows: Class R-6 — 0.65%. This expense limitation excludes interest, taxes, brokerage commissions, costs relating to investments in other investment companies (acquired fund fees and expenses), dividend and interest expenses on short sales, expenses incurred in connection with any merger or reorganization, and extraordinary expenses. The contractual fee waivers can be changed only with the approval of a majority of the fund’s Board of Trustees. Any reimbursement of fund expenses or reduction in Carillon’s investment advisory fees is subject to recoupment by the fund within the following two fiscal years, if overall expenses fall below the lesser of its then-current expense cap or the expense cap in effect at the time of the fee recoupment.

Risk considerations: As with all equity investing, there is the risk that an unexpected change in the market or within the company itself may have an adverse effect on its stock. The biggest risk of equity investing is that returns can fluctuate and investors can lose money.

Growth companies are expected to increase their earnings at a certain rate. When these expectations are not met, investors may punish the stocks excessively, even if earnings showed an absolute increase. Growth company stocks also typically lack the dividend yield that can cushion stock prices in market downturns.

Investments in mid-cap and small-cap companies generally involve greater risks than investing in larger capitalization companies. Mid-cap companies often have narrower commercial markets, more limited managerial and financial resources, and more volatile trading than larger, more established companies.

Quantitative risk involves the dependence on proprietary quantitative tools for security selection which may not be predictive of a security’s value.

Please call 1.800.421.4184 for more information.